Technology, Consumer Discretionary, Healthcare Mar 14, 2022 05:39 PM (GMT+8) · EqualOcean
Shanghai Pharmaceutical announced that the issuance Review Committee of China Securities Regulatory Commission (hereinafter referred to as "CSRC") reviewed the application of Shanghai Pharmaceutical Group Co., Ltd. for non-public issuance of a shares in 2021 on March 14, 2022. According to the review results of the meeting, the company's application for non-public offering of a shares was approved.

This text is a result of machine translation.

Related companies：